Latest News for: biotech

Edit

Biotech Company Creates $5 Million Bitcoin Treasury to Offset Long R&D Times for Clinical Drug Tests

BitRSS 22 Mar 2025
Atai Life Sciences, a Nasdaq-issued biopharmaceutical company, invested $5 million in Bitcoin, creating a treasury plan to hedge against inflation ... .
Edit

Karnataka, Maharashtra frontrunners in booming biotech in last 10 years: Report

Deccan Herald 22 Mar 2025
India’s bio-economy can touch $300 billion in the next five years, nearly doubling from the current volume of $165.7 billion in 2024, according to a new biotech industry report.</p><p>The ...
Edit

Bill & Melinda Gates Foundation To Collaborate With India On Advance Biotech And Vaccine Innovation

MENA FN 21 Mar 2025
(MENAFN - KNN India) New Delhi, Mar 21 (KNN) In a major boost to technology-driven collaboration, Microsoft co-founder and philanthropist Bill Gates met with Union Minister Jitendra Singh during ... .
Edit

Biopharma Executive Suggests Bitcoin As Lifeline For Industry During Biotech Downturn

MENA FN 21 Mar 2025
(MENAFN - Crypto Breaking) The original content cannot be provided as it is copyrighted material. How about I create a new article on a similar topic for you? Crypto Investing Risk Warning Crypto ... .
Edit

Boston cancer biotech cuts 70% of staff

Business Journal 21 Mar 2025
The Boston biotech is also looking into "strategic options" after its only clinical-stage drug showed disappointing Phase 1 trial results ... .
Edit

AstraZeneca invests $2.5B in China for R&D, biotech partnerships

Anadolu Agency 21 Mar 2025
The initiative also includes agreements with leading biotech firms Harbour BioMed, Syneron Bio, and BioKangtai ... the facility will be near top biotechs, research hospitals, and regulatory agencies.
Edit

Biotech Giant Atai Life Sciences Moves Millions into Bitcoin as Inflation Hedge

Crypto Economy 21 Mar 2025
TL;DR Atai Life Sciences, a Germany-based biotech company listed on Nasdaq, will invest $5 million in Bitcoin as part of a new treasury diversification strategy amid global financial uncertainty.
Edit

AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing (AstraZeneca plc)

Public Technologies 21 Mar 2025
Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai ... with three biotechs; Harbour BioMed, Syneron Bio, and BioKangtai, and follows the recent Fibrogen announcement.
Edit

AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing (Form 6-K) (AstraZeneca plc)

Public Technologies 21 Mar 2025
AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing ... Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai.
Edit

Stanziale, Jr. v. Medi Biotech, LLC et al - LETTER RULING regarding Motions to Dismiss (related document(s)12, 35, 44) (LJH) (United States Bankruptcy Court for the District of Delaware)

Public Technologies 21 Mar 2025
). Case 18-50400-BLS Doc 146 Filed 03/20/25 Page 1 of 7. UNITED STATES BANKRUPTCY COURT ... JOHN T ... Re ... Medi Biotech LLC, Adv ... Medi Biotech LLC, Adv ... Medi Biotech LLC, Adv ... Medi Biotech LLC, Adv ... Medi Biotech LLC, Adv ... Medi Biotech LLC, Adv ... Medi Biotech LLC, Adv.
Edit

Stanziale, Jr. v. Medi Biotech, LLC et al - LETTER RULING regarding Motions to Dismiss (related document(s)12, 41, 53) (LJH) (United States Bankruptcy Court for the District of Delaware)

Public Technologies 21 Mar 2025
). Case 18-50401-BLS Doc 174 Filed 03/20/25 Page 1 of 7. UNITED STATES BANKRUPTCY COURT ... JOHN T ... Re ... Medi Biotech LLC, Adv ... Medi Biotech LLC, Adv ... Medi Biotech LLC, Adv ... Medi Biotech LLC, Adv ... Medi Biotech LLC, Adv ... Medi Biotech LLC, Adv ... Medi Biotech LLC, Adv.
Edit

Annual Report for Fiscal Year Ending 12-31, 2024 (Form 10-K) (Moleculin Biotech Inc)

Public Technologies 21 Mar 2025
). MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS ... Our Business Summary ... One is currently beginning a Phase 2B/3 trial ... ● ... ● ... ● ... ● ... ● ... Focus and Core Technologies ... 1 ... a ... b ... 2 ... Moleculin Biotech, Inc ... • ... • ... Moleculin Biotech Inc.
Edit

Registration Statement by Foreign Issuer - Specific Transactions (Form F-3) (Trinity Biotech plc)

Public Technologies 21 Mar 2025
TRINITY BIOTECH PLC ... Trinity Biotech plc, a public limited company organized under the laws of Ireland (the "Company"), filed a combined Registration Statement on Form F-3 (Registration No ... TRINITY BIOTECH PLC ... TRINITY BIOTECH PLC.
×